Constellation Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$940K Buy
11,825
+225
+2% +$20.4K 0.17% 127
2015
Q4
$1.46M Buy
11,600
+175
+2% +$21.1K 0.27% 81
2015
Q3
$1.19M Buy
11,425
+150
+1% +$19.3K 0.25% 88
2015
Q2
$1.39M Buy
11,275
+175
+2% +$22.1K 0.27% 85
2015
Q1
$1.31M Buy
11,100
+325
+3% +$38.9K 0.25% 89
2014
Q4
$1.28M Buy
10,775
+475
+5% +$53.5K 0.26% 88
2014
Q3
$1.16M Buy
10,300
+125
+1% +$11.9K 0.26% 89
2014
Q2
$963K Sell
10,175
-50
-0.5% -$3.51K 0.22% 105
2014
Q1
$723K Buy
10,225
+525
+5% +$41.6K 0.18% 133
2013
Q4
$721K Buy
9,700
+650
+7% +$45.3K 0.18% 127
2013
Q3
$686K Buy
9,050
+4,575
+102% +$364K 0.21% 111
2013
Q2
$357K Buy
+4,475
New +$330K 0.12% 194

Other funds holding VRTX